Abstract:Gene switches have wide utility in synthetic biology, gene therapy, and developmental biology, and multiple orthogonal gene switches are needed to construct advanced circuitry or to control complex phenotypes. Endogenous vascular endothelial growth factor (VEGF-A) is crucial to angiogenesis, and it has been shown that multiple alternately spliced VEGF-A isoforms are necessary for proper blood vessel formation. Such a necessity limits the utility of direct transgene delivery, which can provide only one splice variant. To overcome this limitation, we constructed a gene switch that can regulate the (VEGF-A) locus in mammalian cells by combining an engineered estrogen receptor (ER) ligand-binding domain (LBD), a p65 activation domain, and an artificial zinc-finger DNA binding domain (DBD). Our gene switch is specifically and reversibly controlled by 4,4-dyhydroxybenzil (DHB), a small molecule, non-steroid synthetic ligand, which acts orthogonally in a mammalian system. After optimization of the gene switch architecture, an endogenous VEGF-A induction ratio of >100-fold can be achieved in HEK293 cells at 1 mu M DHB, which is the highest endogenous induction reported to date. In addition, induction has been shown to be reversible, repeatable, and sustainable. Another advantage is that the ligand response is tunable by varying the clonal composition of a stably integrated cell line. The integration of our findings with the technology to change ligand specificity and DNA binding specificity will provide the framework for generating a wide array of orthogonal gene switches that can control multiple genes with multiple orthogonal ligands. Biotechnol. Bioeng. 2013; 110: 14191429. (c) 2012 Wiley Periodicals, Inc.

Creating New Specific Ligand-Receptor Pairs for Transgene Regulation

Directed evolution of specific receptor–ligand pairs for use in the creation of gene switches

Synthetic Protein-Binding DNA Sponge As a Tool to Tune Gene Expression and Mitigate Protein Toxicity

Directed Evolution of Estrogen Receptor Proteins with Altered Ligand-Binding Specificities.

Directed Evolution of Orthogonal Ligand Specificity in a Single Scaffold

DNA-modularized construction of bivalent ligands precisely regulates receptor binding and activation

Synthetic Genes For Dynamic Regulation Of DNA‐Based Receptors

Maßgeschneiderte Liganden für Protein-Protein-Interaktionen

A kinetically controlled platform for ligand-oligonucleotide transduction

Orthogonal Control of Endogenous Gene Expression in Mammalian Cells Using Synthetic Ligands

Rational evolution for altering the ligand preference of estrogen receptor alpha

Protein engineering of gene switches and scissors for human gene therapy

START: A Versatile Platform for Bacterial Ligand Sensing with Programmable Performances

Synthetic G-quadruplex components for predictable, precise two-level control of mammalian recombinant protein expression

[De Novo Construction of Mammalian Synthetic Inhibitory Transcription Factor and Promoter Pairs].

Advances in ligand-specific biosensing for structurally similar molecules

Modulating protein activity using tethered ligands with mutually exclusive binding sites

Engineering transcriptional regulation for cell-based therapies

Introduction to Chemical Ligation Reactions

Multifunctional Systems in Synthetic Biology: Single-Stranded DNA Signaling for Precise Control of Gene Activation

Small-molecule inducible transcriptional control in mammalian cells